uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Interferon-{alpha} and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences. (Kjell Öberg)
2007 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 18, no 1, 13-19 p.Article, review/survey (Refereed) Published
Abstract [en]

In most cases gastro-enteropancreatic neuroendocrine tumors grow slowly. Interferon-α and somatostatin analogs have shown symptomatic, biochemical, and, in a minority of cases, antiproliferative activity. Generally, they are proposed as single-agent therapy. However, based on in vitro and in vivo evidence, the combined use of these drugs was proposed in several non-randomized trials, indicating that there is an additive effect of the combination. Nevertheless, the three randomized trials published so far did not show a statistically significant survival benefit for the combination compared to the same agents alone, even though an advantage for the combination came out in all three studies. On the other hand, data from non-randomized trials would justify the sequential use of the two drugs or the combination after progression on single agent therapy. Therefore, at present the up-front combined use of interferon-α and somatostatin analog is not justified, whereas it could be indicated after progression to single-agent therapy. Further larger, international, prospective, randomized, multicentric clinical trials studying homogeneous populations would be necessary to give a final answer, but the rarity and heterogeneity of this malignancy does not assure that it will be possible.

Place, publisher, year, edition, pages
2007. Vol. 18, no 1, 13-19 p.
Keyword [en]
interferon, neuroendocrine tumors, somatostatin analogs, GEP, carcinoids
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-22936DOI: 10.1093/annonc/mdl144ISI: 000243593700004PubMedID: 16798833OAI: oai:DiVA.org:uu-22936DiVA: diva2:50709
Available from: 2007-02-08 Created: 2007-02-08 Last updated: 2011-03-29Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16798833&dopt=Citation

Search in DiVA

By author/editor
Öberg, Kjell
By organisation
Department of Medical Sciences
In the same journal
Annals of Oncology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 138 hits
ReferencesLink to record
Permanent link

Direct link